- Home
- FINW vs CDTX Comparison
FINW vs CDTX Comparison
Compare FINW & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FINW
- CDTX
- Stock Information
- Founded
- FINW 1999
- CDTX 2012
- Country
- FINW United States
- CDTX United States
- Employees
- FINW N/A
- CDTX N/A
- Industry
- FINW Commercial Banks
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FINW Finance
- CDTX Health Care
- Exchange
- FINW Nasdaq
- CDTX Nasdaq
- Market Cap
- FINW 212.8M
- CDTX 229.0M
- IPO Year
- FINW 2021
- CDTX 2015
- Fundamental
- Price
- FINW $16.41
- CDTX $21.70
- Analyst Decision
- FINW Buy
- CDTX Strong Buy
- Analyst Count
- FINW 3
- CDTX 6
- Target Price
- FINW $18.67
- CDTX $32.20
- AVG Volume (30 Days)
- FINW 15.2K
- CDTX 127.4K
- Earning Date
- FINW 01-30-2025
- CDTX 11-07-2024
- Dividend Yield
- FINW N/A
- CDTX N/A
- EPS Growth
- FINW N/A
- CDTX N/A
- EPS
- FINW 1.06
- CDTX N/A
- Revenue
- FINW $69,509,000.00
- CDTX $44,653,000.00
- Revenue This Year
- FINW N/A
- CDTX N/A
- Revenue Next Year
- FINW $10.13
- CDTX N/A
- P/E Ratio
- FINW $15.52
- CDTX N/A
- Revenue Growth
- FINW 4.87
- CDTX 44.48
- 52 Week Low
- FINW $8.72
- CDTX $10.00
- 52 Week High
- FINW $20.50
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- FINW 48.28
- CDTX 46.63
- Support Level
- FINW $15.33
- CDTX $19.87
- Resistance Level
- FINW $16.69
- CDTX $27.70
- Average True Range (ATR)
- FINW 0.60
- CDTX 2.33
- MACD
- FINW 0.06
- CDTX -0.79
- Stochastic Oscillator
- FINW 63.72
- CDTX 21.40
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank also has established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.